Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Clinical cancer research, 2020-08, Vol.26 (16), p.4206-4215
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Scientific reports, 2021-02, Vol.11 (1), p.4433-11, Article 4433
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Challenges in the management of neuroendocrine cervical cancer during pregnancy: A case report
Molecular and clinical oncology, 2018-11, Vol.9 (5), p.519-522
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
The Lancet (British edition), 2024-01, Vol.403 (10421), p.31-43
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
ESMO open, 2019, Vol.4 (2), p.e000444-e000444, Article e000444
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Journal of clinical oncology, 2023-12, Vol.41 (35), p.5400-5410
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)
International journal of gynecological cancer, 2020-01, Vol.30 (1), p.139-143
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study
Cancers, 2022-02, Vol.14 (4), p.915
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Advances in immunotherapy in cervical cancer
International journal of gynecological cancer, 2023-03, Vol.33 (3), p.403-413
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Immunotherapy in the treatment of advanced or recurrent endometrial cancer
Clinical advances in hematology & oncology, 2024-04, Vol.22 (3), p.129-139
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
The lancet oncology, 2024-09, Vol.25 (9), p.1135-1146
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Laboratory cross-comparison of tumor BRCA1/2 analysis in a multicenter epithelial ovarian cancer series: The BORNEO GEICO60-0 study
Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6055-6055
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase 1 of ABTL0812, a proautophagic drug, in combination with paclitaxel and carboplatin at first-line in advanced endometrial cancer and squamous cell lung carcinoma
Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3089-3089
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
711 Long-term survival women with advanced-stage high-grade serous carcinoma of the ovary, peritoneum, or fallopian tube: digging into their clinico-molecular features
International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A357-A357
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Non-comparative, open-label, international, multicenter phase I/II study of nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with recurrent/metastatic merkel cell carcinoma (MCC) (CheckMate 358)
Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9506-9506
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients
Blood, 2023-11, Vol.142 (Supplement 1), p.5593-5593
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
806 Assessment of the RAD51 test to determine homologous recombination deficiency (HRD) in patients with newly diagnosed advanced high-grade epithelial ovarian cancer carcinoma (HGOC)
International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A504-A505
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), safety and efficacy in a broad distribution of FolRα expression in patients with recurrent epithelial ovarian cancer (OC): Update of STRO-002-GM1 phase 1 dose expansion cohort
Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5508-5508
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Copy number features as a novel biomarker of homologous recombination (HR) status in high-grade serous ovarian cancer (HGSOC)
Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5547-5547
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Gynecologic oncology, 2024-06, Vol.185, p.202-211
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
427 BEATcc (ENGOT-CX10/GEICO 68-C/JGOG1084/GOG-3030), a randomised phase 3 trial of first-line atezolizumab with bevacizumab and platinum-based chemotherapy for metastatic (stage IVB), persistent or recurrent cervical cancer
International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A6-A7
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
546 AtTEnd/ENGOT-EN7: phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma
International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A21-A21
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Laboratory cross-comparison of homologous recombination repair mutation analysis in tumor in a multicenter epithelial ovarian cancer series: The BORNEO GEICO 60-0 study
Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e17550-e17550
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Platinum rechallenge (PtRc) in platinum-resistant epithelial ovarian cancer (PR-EOC) patients: Is platinum-resistance a static or a dynamic status? (485)
Gynecologic oncology, 2022-08, Vol.166, p.S240
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I study to evaluate the tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) of PM01183 (Lurbinectedin) in combination with olaparib in patients with advanced solid tumors
Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5573-5573
2017
Volltextzugriff (PDF)
1 – 25 von 27
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen